No Data
No Data
Neuronetics to Present at the William Blair 44th Annual Growth Stock Conference
MALVERN, Pa., May 23, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ:STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who
Express News | Neuronetics Announced That Humana Has Become The First Commercial Payer To Address TMS Therapy Coverage For Adolescents
Humana Is First Commercial Payer to Address TMS Therapy Coverage for Adolescents
MALVERN, Pa., May 15, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ:STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who
Neuronetics Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/14/2024 — William Blair Upgrades Market Perform → Outperform 03/06/2024 207.69% Piper Sandler $7 → $8
Express News | Neuronetics Inc : William Blair Raises to Outperform Rating
Strong Buy Rating for Neuronetics Backed by Solid Financials and Growth Prospects